| |
|
|
|
Clovis Oncology Inc.  
|
|
6.965 -0.515 (-0.07%) |
09-18 16:00 |
|
Open: |
7.5 |
Pre close: |
7.48 |
Target:
|
9.31
|
|
High: |
7.52 |
Low: |
6.73 |
Resistance:
|
7.97
9.31
|
|
Volume: |
8,529,715 |
Market Cap: |
644M |
Support:
|
5.98
4.75
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
7.26
 |
MACD |
MACD(12,26):
|
0.41 |
|
MA(20): |
5.76 |
Signal(12,26,9): |
0.15 |
|
MA(100): |
6.66  |
Stochastic Oscillator |
%K(14,3):
|
83.33 |
|
MA(250): |
7.17 |
%D(3): |
90.18 |
|
Average Volume(K) |
3-Month: |
483163
|
52-Week |
High:
|
17.37 |
|
10-Days: |
687731 |
Low: |
2.93 |
|
RSI |
RSI(14):
|
62.50 |
Change(%): |
51.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-5.890 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
88.20 |
|
EPS Est. Current Year |
-7.580 |
Return on Assets (ttm) |
-33.6 |
Shares Float (M) |
85.08 |
|
EPS Est. Next Year |
-2.460 |
PEG Ratio |
0.00 |
% Held by Insiders |
2.27 |
|
EPS Est. Next Quarter |
-1.150 |
Qtrly Rev. Growth |
21.0 |
% Held by Institutions |
48.46 |
|
Forward EPS |
-7.430 |
Gross Profit (p.s.) |
1.282 |
Shares Short (K) |
36570 |
|
Book Value (p.s.) |
-1.100 |
EBITDA (p.s.) |
-3.912 |
P/E |
-1.18 |
|
Sales Per Share |
1.807 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-6.33 |
|
Profit Margin |
-241.69 |
Operating Cash Flow
(M) |
-269.48 |
P/S |
3.85 |
|
Operating Margin |
-221.70 |
Levered Free Cash Flow
(M) |
-149.04 |
P/CF |
-2.28 |
|
|
|
|
|
|
